Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?

Open access
Carter, H. Ballentine, Partin, Alan W., Walsh, Patrick C., Trock, Bruce J., Veltri, Robert W., Nelson, William G., Coffey, Donald S., Singer, Eric A., Epstein, Jonathan I.·2012·Journal of Clinical Oncology

Abstract

Overtreatment of low-grade prostate cancer (Gleason score 6) is a recognized problem today, with systematic prostate gland sampling triggered by prostate-specific antigen (PSA) measurements. The extent to which overtreatment is caused by fear of death resulting from cancer, fear of litigation from undertreatment, and misaligned incentives that reimburse more for treating rather than monitoring when appropriate is not known. Nevertheless, fear of death resulting from cancer likely plays some role, and removing the label “cancer” could reduce unnecessary treatment of low-grade disease. On the other hand, undertreatment of prostate cancer and a missed opportunity for cure in those who could benefit is a real risk of relabeling a cancer as noncancer. We have decided on an alternative modification of the Gleason scoring system and herein present the arguments for and against removing the label of cancer from Gleason 6 tumors. We believe that our alternative approach may help: one, ensure that patients receive the proper counseling/treatment; two, reduce the risk of overtreatment and its associated harms; and three, improve shared decision making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2012.44.0586

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 169

Metadata

Authors
Carter, H. B., Partin, A. W., Walsh, P. C., Trock, B. J., Veltri, R. W., Nelson, W. G., Coffey, D. S., Singer, E. A., & Epstein, J. I.
Venue
Journal of Clinical Oncology
Published
2012-12-10
Volume
30
Issue
35
Pages
4294-4296
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2148659100
Cited by
169
References
1
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer? https://app.cochat.ai/papers/10.1200/jco.2012.44.0586
The paper
Carter, H. B., Partin, A. W., Walsh, P. C., Trock, B. J., Veltri, R. W., Nelson, W. G., Coffey, D. S., Singer, E. A., & Epstein, J. I. (2012). Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer? Journal of Clinical Oncology. https://doi.org/10.1200/jco.2012.44.0586

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.